National Bank of Canada’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.16K | Hold |
700
| – | – | ﹤0.01% | 2253 |
|
|
2025
Q1 | $2.44K | Sell |
700
-907
| -56% | -$3.17K | ﹤0.01% | 2154 |
|
|
2024
Q4 | $5.26K | Sell |
1,607
-97
| -6% | -$317 | ﹤0.01% | 2065 |
|
|
2024
Q3 | $6.56K | Sell |
1,704
-1,006
| -37% | -$3.87K | ﹤0.01% | 1973 |
|
|
2024
Q2 | $8.43K | Buy |
2,710
+1,000
| +58% | +$3.11K | ﹤0.01% | 2008 |
|
|
2024
Q1 | $4.92K | Sell |
1,710
-110
| -6% | -$317 | ﹤0.01% | 2115 |
|
|
2023
Q4 | $4.69K | Hold |
1,820
| – | – | ﹤0.01% | 2143 |
|
|
2023
Q3 | $3.45K | Sell |
1,820
-300
| -14% | -$569 | ﹤0.01% | 2200 |
|
|
2023
Q2 | $4.87K | Hold |
2,120
| – | – | ﹤0.01% | 2175 |
|
|
2023
Q1 | $6.41K | Hold |
2,120
| – | – | ﹤0.01% | 2099 |
|
|
2022
Q4 | $4.92K | Buy |
2,120
+300
| +16% | +$696 | ﹤0.01% | 2168 |
|
|
2022
Q3 | $3K | Hold |
1,820
| – | – | ﹤0.01% | 2244 |
|
|
2022
Q2 | $5K | Hold |
1,820
| – | – | ﹤0.01% | 2200 |
|
|
2022
Q1 | $5K | Hold |
1,820
| – | – | ﹤0.01% | 2291 |
|
|
2021
Q4 | $7K | Buy |
+1,820
| New | +$7K | ﹤0.01% | 2215 |
|